Author: Beekman N.J.C.M. Schaaper W.M.M. Turkstra J.A. Meloen R.H.
Publisher: Elsevier
ISSN: 0264-410X
Source: Vaccine, Vol.17, Iss.15, 1999-04, pp. : 2043-2050
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Totally synthetic lipid-containing polyoxime peptide constructs are potent immunogens
By Zeng W. Jackson D.C. Murray J. Rose K. Brown L.E.
Vaccine, Vol. 18, Iss. 11, 2000-01 ,pp. :
By del Guercio M.-F. Alexander J. Kubo R.T. Arrhenius T. Maewal A. Appella E. Hoffman S.L. Jones T. Valmori D. Sakaguchi K. Grey H.M. Sette A.
Vaccine, Vol. 15, Iss. 4, 1997-03 ,pp. :
Producing a highly immunogenic synthetic vaccine construct active against HIV-1 subtype C
Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. :
By Nardin E.H. Calvo-Calle J.M. Oliveira G.A. Clavijo P. Nussenzweig R. Simon R. Zeng W. Rose K.
Vaccine, Vol. 16, Iss. 6, 1998-04 ,pp. :